|
|
|
Issue Open Date
|
10-Dec-25
|
|
|
|
Issue Closing Date
|
12-Dec-25
|
|
|
|
Application Money
|
100
|
|
|
|
Allotment Money
|
|
|
|
|
|
|
|
Price Band
|
438
-
460
|
|
|
|
Minimium Application No.
|
32
|
|
|
|
Issue Size (Shares)
|
13387854
|
|
|
|
Market Lot
|
1
|
|
|
|
|
|
Objective
|
|
1. Capital expenditure by our Company for opening new dialysis clinics in India and;2. Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by our Company; and 3. General corporate purposes.
|
|
|
|
|
|
|
Category
|
No. of Shares
|
No. of Shares
|
Subscription Ratio
|
|
|
Offered / Reserved |
Bid For |
|
|
Non-Institutional Investors
|
2886270
|
70051008
|
24.27
|
|
Qualified Institutional Buyers
|
3678793
|
101069088
|
27.47
|
|
Retail Individual Investors
|
6734630
|
15537280
|
2.31
|
|
|
|
|
Business Description
We offer comprehensive dialysis care through our network of clinics – from diagnosis to treatment and wellnessprograms including haemodialysis, home and mobile dialysis, supported by pharmacy. We are India’s largestdialysis service provider in terms of number of patients served, clinics, cities covered, treatments performed,revenue, and EBITDA (excluding other income) in Fiscal 2025, and it is 4.4 times the size of the next largestorganized dialysis provider in India in terms of operating revenue in Fiscal 2024. (Source: F&S Report) In Fiscal2025, we served 29,281 patients and completed 2,885,450 treatments in India which represented approximately10% of the total dialysis patients in India. (Source: F&S Report) We are also the largest dialysis service providerin Asia in 2025 and the fifth largest globally based on the number of treatments performed in Fiscal 2025.
|
|
|
Promoter's Holding
|
|
|
|
Total Share Capital
|
|
|
|
|
Offered to Public
|
18935819
|
|
|
|
Promoter's Holding (Pre-Issue)
|
|
|
|
|
Promoter's Holding (Post-Issue)
|
|
|
|
|
|
|
|
|
|
|
|
Address |
5th Floor
D Block
Ilabs Centre
Plot 18
Software Units Layout
Survey No. 64
Madhapur
Shaikpet
Hyderabad,
Telangana,
500081
Phone : 040 4240 8039
Email : cs@nephroplus.com
Website : www.nephroplus.com
|
|
|
Registrar |
KFIN Technologies Ltd.
301
The Centrium
3rd Floor
57
Lal Bahadur Shastri Road
Nav Pada
Kurla (West)
Mumbai
|
|
|
Listed at |
|
BSE, NSE
|
|
|
Lead Manager |
Ambit Pvt Ltd.
ICICI Securities Ltd
IIFL Capital Services Ltd.
Nomura Financial Advisory & Securities (India) Pvt Ltd.
|
|
|
Promoters |
Bessemer Venture Partners Trust
Edoras Investment Holdings PTE. Ltd.
HEALTHCARE PARENT Ltd.
Investcorp Growth Opportunity Fund
Investcorp PVT Equity Fund II
Vikram Vuppala
|
|
